Transcat paid its 5 named executives $4.5M in total in FY2025 (Mar). CEO Lee D. Rudow was paid $1.8M of that.
Pay$100 in the stock at the end of FY20 → $281
Pay of each named executive
Lee D. RudowPresident and Chief Executive Officer
| FY2025 (Mar) | |||||||
| FY2024 (Mar) | |||||||
| FY2023 (Mar) | |||||||
| FY2022 (Mar) | Not disclosed | ||||||
| FY2021 (Mar) | Not disclosed |
5 years
Thomas BarbatoChief Financial Officer
| FY2025 (Mar) | |||||||
| FY2024 (Mar) | |||||||
| FY2023 (Mar) |
3 years
Michael W. WestChief Operating Officer
| FY2025 (Mar) | |||||||
| FY2024 (Mar) | Not disclosed | ||||||
| FY2023 (Mar) | Not disclosed |
3 years
Theresa A. ConroySenior Vice President, Human Resources
| FY2025 (Mar) | |||||||
| FY2024 (Mar) | |||||||
| FY2023 (Mar) |
3 years
Michael J. HaddadChief Information Officer
| FY2025 (Mar) |
1 year
CEO pay against the pay peers
In FY2025 (Mar), the median CEO pay of the 3 peers with pay on file was $3.6M. The CEO of Transcat was paid $1.8M, 50% below the median.
- 1Willis Lease Finance
- 2Powell Industries
- 3Argan
- 4TranscatThis company
- 5AeroVironmentNot disclosed
- 6CIRCOR International, Inc.Not disclosed
- 7Cryoport, Inc.Not disclosed
- 8Cutera, Inc.Not disclosed
- 9Ducommun IncorporatedNot disclosed
- 10Enzo Biochem, Inc.Not disclosed
- 11Harvard Bioscience, Inc.Not disclosed
- 12InfuSystem Holdings, Inc.Not disclosed
- 13Inogen, Inc.Not disclosed
- 14Kaman CorporationNot disclosed
- 15Lemaitre VascularNot disclosed
- 16Ligand PharmaceuticalsNot disclosed
- 17Mesa Laboratories, Inc.Not disclosed
- 18Standex International CorporationNot disclosed
- 19Surmodics, Inc.Not disclosed
- 20Twin Disc, IncorporatedNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.